Integrated analysis of 18F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer

Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion

(2017) Minsu Lee et al.   EUROPEAN RADIOLOGY

An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer

(2017) Valeria Panebianco et al.   EUROPEAN RADIOLOGY

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

Systematic Review of Immune Checkpoint Inhibition in Urological Cancers

(2017) Maud Rijnders et al.   EUROPEAN UROLOGY

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

(2017) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Bladder cancer

(2017) Oner Sanli et al.   Nature Reviews Disease Primers

68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging

(2016) Thorsten Derlin et al.   EUROPEAN RADIOLOGY

Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study

(2016) Huyen T. Nguyen et al.   EUROPEAN RADIOLOGY

Bladder cancer

(2016) Ashish M Kamat et al.   LANCET

The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis

(2016) Ayman Soubra et al.   WORLD JOURNAL OF UROLOGY

Is [F-18]-fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer?

(2016) Mete Uttam et al.   International Braz J Urol

FDG PET–CT for Lymph Node Staging of Bladder Cancer: A Prospective Study of Patients with Extended Pelvic Lymphadenectomy

(2015) In Gab Jeong et al.   ANNALS OF SURGICAL ONCOLOGY

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer

(2015) Firas Aljabery et al.   BMC Urology

Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy

(2014) M. Rouanne et al.   EJSO

Impact of18F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle

(2013) Laura S. Mertens et al.   BJU INTERNATIONAL

Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration–voiding–refilling) useful for detecting recurrent bladder cancer?

(2012) Zhongyi Yang et al.   ANNALS OF NUCLEAR MEDICINE

Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: Long-Term Results in 1100 Patients

(2012) Richard E. Hautmann et al.   EUROPEAN UROLOGY

18F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: A prospective study

(2012) Maryam Hitier-Berthault et al.   INTERNATIONAL JOURNAL OF UROLOGY

Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer

(2010) Andrea B. Apolo et al.   JOURNAL OF CLINICAL ONCOLOGY

FDG-PET/CT for the Preoperative Lymph Node Staging of Invasive Bladder Cancer

(2009) Greet Swinnen et al.   EUROPEAN UROLOGY

Prospective Study of [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Muscle-Invasive Bladder Carcinoma

(2009) Adam S. Kibel et al.   JOURNAL OF CLINICAL ONCOLOGY